STAT

TV personality Dr. Oz is now on the board of a biotech company

Dr. Oz, a surgeon turned Emmy-winning daytime television talk show, is now also a member of the board of a biotech company.
Dr. Mehmet Oz

One biotech company’s newest director has a very familiar face. Dr. Mehmet Oz will be joining the board of directors of PanTheryx, a Colorado-based nutraceutical and biologics company, the company recently announced.

Oz, the host of “The Dr. Oz Show,” commands a huge following. He has also drawn sharp criticism for his embrace of

You’re reading a preview, subscribe to read more.

More from STAT

STAT2 min read
STAT+: Pharmalittle: We’re Reading About Plans For Generic Wegovy, Cough Syrup Warnings, And More
Biocon is developing a generic version of Novo Nordisk's Wegovy and is prepared to conduct a clinical trial next year if needed.
STAT2 min read
STAT+: Pharmalittle: We’re Reading About Cigna Biosimilar Plans, A Vertex Deal In South Africa, And More
Cigna plans to make copies of AbbVie's Humira arthritis drug available with no out-of-pocket payment to eligible patients in the U.S.
STAT2 min read
STAT+: Pharmalittle: We’re Reading About MorphoSys Drug Risks, An AstraZeneca Admission, And More
MorphoSys is dealing with a safety issue with pelabresib, the experimental treatment for myelofibrosis and centerpiece of its proposed $3 billion acquisition by Novartis.

Related Books & Audiobooks